(Q73959236)
English
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Bl
scientific article published on 01 June 2001
Statements
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group (English)
H Holte
A H Goldstone
J W Sweetenham
G Santini
W Qian
M Guelfi
N Schmitz
S Simnett
A Nagler
S Kvaloy